Amyloid beta: structure, biology and structure-based therapeutic development
Guo-fang Chen, Ting-Hai Xu, Yan Yan et al. · Acta Pharmacologica Sinica · 2017
Cited by 1,951 works. doi:10.1038/aps.2017.28 Open-access PDF
Authors
References
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
- Proceedings of the National Academy of Sciences of the United States of America
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
- Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
- Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
- Amyloid β-peptide is produced by cultured cells during normal metabolism
- Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
- Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
- Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment